Abeona Therapeutics Inc (ABEO)
4.23
-0.07
(-1.63%)
USD |
NASDAQ |
May 14, 14:42
Abeona Therapeutics Cash from Investing (Quarterly): 11.53M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 11.53M |
| September 30, 2023 | -18.74M |
| June 30, 2023 | 5.211M |
| March 31, 2023 | 2.211M |
| December 31, 2022 | -25.29M |
| September 30, 2022 | 1.649M |
| June 30, 2022 | -1.398M |
| March 31, 2022 | 1.075M |
| December 31, 2021 | 7.999M |
| September 30, 2021 | 26.76M |
| June 30, 2021 | 21.92M |
| March 31, 2021 | 9.376M |
| December 31, 2020 | 5.782M |
| September 30, 2020 | 4.584M |
| June 30, 2020 | -18.21M |
| March 31, 2020 | -75.87M |
| December 31, 2019 | -0.946M |
| September 30, 2019 | 19.23M |
| June 30, 2019 | 18.92M |
| March 31, 2019 | 22.77M |
| December 31, 2018 | 2.119M |
| September 30, 2018 | -10.43M |
| June 30, 2018 | -73.27M |
| March 31, 2018 | -3.502M |
| December 31, 2017 | -0.704M |
| Date | Value |
|---|---|
| September 30, 2017 | -0.072M |
| June 30, 2017 | -0.01M |
| March 31, 2017 | -0.074M |
| December 31, 2016 | -0.018M |
| September 30, 2016 | -0.148M |
| June 30, 2016 | -0.126M |
| March 31, 2016 | -0.227M |
| December 31, 2015 | -0.267M |
| September 30, 2015 | -0.027M |
| June 30, 2015 | 3.692M |
| March 31, 2015 | -0.009M |
| December 31, 2014 | |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | -0.001M |
| September 30, 2013 | -0.001M |
| June 30, 2013 | |
| March 31, 2013 | |
| December 31, 2012 | 0.002M |
| September 30, 2012 | 0.00 |
| June 30, 2012 | -0.002M |
| March 31, 2012 | -0.013M |
| December 31, 2011 | 0.00 |
| September 30, 2011 | -0.001M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-75.87M
Minimum
Mar 2020
26.76M
Maximum
Sep 2021
-0.2214M
Average
4.584M
Median
Sep 2020
Cash from Investing (Quarterly) Benchmarks
| T2 Biosystems Inc | 0.00 |
| INVO Bioscience Inc | 0.0333M |
| Perspective Therapeutics Inc | -0.089M |
| Electromed Inc | -0.129M |
| Xtant Medical Holdings Inc | -2.313M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -9.235M |
| Cash from Financing (Quarterly) | 7.467M |
| Free Cash Flow | -37.34M |
| Free Cash Flow Per Share (Quarterly) | -0.3609 |
| Free Cash Flow Yield | -41.34% |